Efrat Broide

2.8k total citations
117 papers, 1.8k citations indexed

About

Efrat Broide is a scholar working on Surgery, Epidemiology and Genetics. According to data from OpenAlex, Efrat Broide has authored 117 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Surgery, 43 papers in Epidemiology and 39 papers in Genetics. Recurrent topics in Efrat Broide's work include Inflammatory Bowel Disease (37 papers), Microscopic Colitis (34 papers) and Eosinophilic Esophagitis (26 papers). Efrat Broide is often cited by papers focused on Inflammatory Bowel Disease (37 papers), Microscopic Colitis (34 papers) and Eosinophilic Esophagitis (26 papers). Efrat Broide collaborates with scholars based in Israel, United States and United Kingdom. Efrat Broide's co-authors include Raanan Shamir, Yoram Bujanover, Batia Weiss, Haim Shirin, Amit Assa, Ron Shaoul, Baruch Yerushalmi, Eitan Scapa, Erez Scapa and Arie Levine and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and American Journal of Clinical Nutrition.

In The Last Decade

Efrat Broide

110 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Efrat Broide Israel 25 783 753 726 339 200 117 1.8k
Jérôme Filippi France 21 729 0.9× 1.0k 1.4× 799 1.1× 467 1.4× 207 1.0× 58 2.1k
Carmen Cuffari United States 22 590 0.8× 730 1.0× 433 0.6× 218 0.6× 184 0.9× 71 1.7k
Wael El‐Matary Canada 28 755 1.0× 1.1k 1.5× 907 1.2× 392 1.2× 206 1.0× 121 2.1k
Corina Hartman Israel 24 575 0.7× 537 0.7× 595 0.8× 268 0.8× 112 0.6× 74 2.3k
Mary Zachos Canada 17 792 1.0× 1.6k 2.1× 1.1k 1.5× 190 0.6× 360 1.8× 39 2.3k
Gordon W. Moran United Kingdom 21 536 0.7× 927 1.2× 698 1.0× 203 0.6× 201 1.0× 96 1.5k
André Archambault Canada 11 548 0.7× 906 1.2× 741 1.0× 242 0.7× 169 0.8× 14 1.5k
Arthur Barrie United States 24 454 0.6× 961 1.3× 813 1.1× 156 0.5× 253 1.3× 84 1.6k
Marc Schwartz United States 23 459 0.6× 1.0k 1.4× 853 1.2× 196 0.6× 153 0.8× 76 1.5k
Hye Ran Yang South Korea 23 596 0.8× 189 0.3× 485 0.7× 204 0.6× 102 0.5× 133 1.6k

Countries citing papers authored by Efrat Broide

Since Specialization
Citations

This map shows the geographic impact of Efrat Broide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Efrat Broide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Efrat Broide more than expected).

Fields of papers citing papers by Efrat Broide

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Efrat Broide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Efrat Broide. The network helps show where Efrat Broide may publish in the future.

Co-authorship network of co-authors of Efrat Broide

This figure shows the co-authorship network connecting the top 25 collaborators of Efrat Broide. A scholar is included among the top collaborators of Efrat Broide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Efrat Broide. Efrat Broide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Peyrin‐Biroulet, Laurent, Jesse Siffledeen, Efrat Broide, et al.. (2023). OP16 Endoscopic and clinical outcomes of upadacitinib in patients with moderately to severely active Crohn’s disease by number and type of prior biologics. Journal of Crohn s and Colitis. 17(Supplement_1). i20–i22. 4 indexed citations
3.
Atia, Ohad, Raffi Lev‐Tzion, Richard I. Stein, et al.. (2023). P774 Maintenance treatment with vedolizumab in children with Inflammatory Bowel Disease: follow-up results from the prospective multicenter VEDOKIDS study. Journal of Crohn s and Colitis. 17(Supplement_1). i904–i905. 2 indexed citations
4.
5.
Assa, Amit, Manar Matar, Dan Turner, et al.. (2019). Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn’s Disease Compared With Reactive Monitoring. Gastroenterology. 157(4). 985–996.e2. 175 indexed citations
6.
Naftali, Timna, Ariella Bar‐Gil Shitrit, Ido Laish, et al.. (2019). Sense of Coherence in People with and without Inflammatory Bowel Diseases – Is there a Difference?. Journal of Gastrointestinal and Liver Diseases. 28(1). 29–32. 2 indexed citations
7.
Broide, Efrat, et al.. (2017). Lymphoid follicles in children with Helicobacter pylori-negative gastritis. SHILAP Revista de lepidopterología. 1 indexed citations
8.
Matalon, Shay, et al.. (2016). Real‐world Helicobacter pylori diagnosis in patients referred for esophagoduodenoscopy: The gap between guidelines and clinical practice. United European Gastroenterology Journal. 4(6). 762–769. 9 indexed citations
9.
Shapiro, Michael, Ronit Simantov, Marina Leitman, et al.. (2012). Comparison of central and intraesophageal factors between gastroesophageal reflux disease (GERD) patients and those with GERD-related noncardiac chest pain. Diseases of the Esophagus. 25(8). 702–708. 8 indexed citations
10.
Broide, Efrat, et al.. (2010). Intima-Media Thickness of the Common Carotid Artery Is Not Significantly Higher in Crohn’s Disease Patients Compared to Healthy Population. Digestive Diseases and Sciences. 56(1). 197–202. 21 indexed citations
11.
Levine, Arie, Michal Kori, Gabriel Dinari, et al.. (2009). Comparison of two dosing methods for induction of response and remission with oral budesonide in active pediatric Crohnʼs disease: A randomized placebo-controlled trial. Inflammatory Bowel Diseases. 15(7). 1055–1061. 25 indexed citations
12.
Segal, Idit, Yasmin Yaakov, Samuel N. Adler, et al.. (2008). Cystic Fibrosis Transmembrane Conductance Regulator Ion Channel Function Testing in Recurrent Acute Pancreatitis. Journal of Clinical Gastroenterology. 42(7). 810–814. 17 indexed citations
13.
Weiss, Batia, et al.. (2008). Is Adult Height of Patients With Celiac Disease Influenced by Delayed Diagnosis. The American Journal of Gastroenterology. 103(7). 1770–1774. 25 indexed citations
14.
15.
Broide, Efrat, et al.. (2004). CHRONIC HEPATITIS C IN ISRAELI CHILDREN. Fetal and Pediatric Pathology. 23(4). 231–239.
16.
Levine, Arie, Zvi Weizman, Efrat Broide, et al.. (2003). A Comparison of Budesonide and Prednisone for the Treatment of Active Pediatric Crohn Disease. Journal of Pediatric Gastroenterology and Nutrition. 36(2). 248–252. 58 indexed citations
17.
Broide, Efrat, Andreas Buchs, Abraham Kornberg, et al.. (2002). Lack of Correlation between Disease Activity and Decreased Stimulated Secretion of IL-10 in Lymphocytes from Patients with Celiac Disease. Scandinavian Journal of Gastroenterology. 37(8). 924–930. 9 indexed citations
18.
Broide, Efrat, George Koukoulis, Nedim Hadžić, et al.. (2000). Superoxide dismutase activity in children with chronic liver diseases. Journal of Hepatology. 32(2). 188–192. 27 indexed citations
19.
Broide, Efrat, Orly Elpeleg, & Eli Lahat. (1997). Type IV 3-Methylglutaconic (3-MGC) aciduria: A new case presenting with hepatic dysfunction. Pediatric Neurology. 17(4). 353–355. 7 indexed citations
20.
Broide, Efrat, et al.. (1996). Superoxide Dismutase Activity in Helicobacter pylori—Positive Antral Gastritis in Children. Journal of Pediatric Gastroenterology and Nutrition. 23(5). 609–613. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jérôme Filippi Breakdown of academic impact, for papers by Carmen Cuffari Breakdown of academic impact, for papers by Wael El‐Matary Breakdown of academic impact, for papers by Corina Hartman Breakdown of academic impact, for papers by Mary Zachos Breakdown of academic impact, for papers by Gordon W. Moran Breakdown of academic impact, for papers by André Archambault Breakdown of academic impact, for papers by Arthur Barrie Breakdown of academic impact, for papers by Marc Schwartz Breakdown of academic impact, for papers by Hye Ran Yang
Rankless by CCL
2026